Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G S Leverich

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
International Clinical Psychopharmacology|April 27, 2004
Use of quetiapine in bipolar disorder: a case series with prospective evaluationT Suppes, S L McElroy, P E Keck, et al.
Acta Psychiatrica Scandinavica|October 22, 2013
Increased parental history of bipolar disorder in the United States: association with early age of onsetR M Post, G S Leverich, R Kupka, et al.
Journal of Clinical Psychopharmacology|December 6, 2000
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disordersM A Frye, T A Ketter, T A Kimbrell, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodologyG S Leverich, W A Nolen, A J Rush, et al.
Acta Psychiatrica Scandinavica|April 14, 2007
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful studyW A Nolen, R W Kupka, G Hellemann, et al.
Bipolar Disorders|March 26, 2002
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizersR M Post, L L Altshuler, M A Frye, et al.
Journal of Clinical Psychopharmacology|October 28, 1998
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illnessP J Pazzaglia, R M Post, T A Ketter, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatmentsR W Kupka, W A Nolen, L L Altshuler, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patientsT Suppes, G S Leverich, P E Keck, et al.
Biological Psychiatry|June 23, 2000
Open-label adjunctive topiramate in the treatment of bipolar disordersS L McElroy, T Suppes, P E Keck, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
International Clinical Psychopharmacology|April 27, 2004
Use of quetiapine in bipolar disorder: a case series with prospective evaluationT Suppes, S L McElroy, P E Keck, et al.
Acta Psychiatrica Scandinavica|October 22, 2013
Increased parental history of bipolar disorder in the United States: association with early age of onsetR M Post, G S Leverich, R Kupka, et al.
Journal of Clinical Psychopharmacology|December 6, 2000
A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disordersM A Frye, T A Ketter, T A Kimbrell, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodologyG S Leverich, W A Nolen, A J Rush, et al.
Acta Psychiatrica Scandinavica|April 14, 2007
Tranylcypromine vs. lamotrigine in the treatment of refractory bipolar depression: a failed but clinically useful studyW A Nolen, R W Kupka, G Hellemann, et al.
Bipolar Disorders|March 26, 2002
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizersR M Post, L L Altshuler, M A Frye, et al.
Journal of Clinical Psychopharmacology|October 28, 1998
Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illnessP J Pazzaglia, R M Post, T A Ketter, et al.
The British Journal of Psychiatry. Supplement|July 14, 2001
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatmentsR W Kupka, W A Nolen, L L Altshuler, et al.
Journal of Affective Disorders|March 1, 2002
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patientsT Suppes, G S Leverich, P E Keck, et al.
Biological Psychiatry|June 23, 2000
Open-label adjunctive topiramate in the treatment of bipolar disordersS L McElroy, T Suppes, P E Keck, et al.
Pageof 5